Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$342K
Shares
1,200
Price
$285
Executed
Sep 10, 2026
Disclosed
Sep 14, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 10 executedSep 14, 2026 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zimmermann Martine filed this Form 4 reporting a open-market sale of LGND on Sep 10, 2026. It became public on Sep 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Zimmermann Martinecik:0001994049
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
